Compounds > mofezolac

mofezolac and sc 560

mofezolac has been researched along with sc 560 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Fortuna, CG; Panella, A; Perrone, MG; Scilimati, A; Vitale, P1
Bhardwaj, A; Kaur, J; Wuest, F1
Carazo, A; Konečný, L; Landa, P; Mladěnka, P; Sisa, M; Temml, V1

Other Studies

3 other study(ies) available for mofezolac and sc 560

ArticleYear
General role of the amino and methylsulfamoyl groups in selective cyclooxygenase(COX)-1 inhibition by 1,4-diaryl-1,2,3-triazoles and validation of a predictive pharmacometric PLS model.
    European journal of medicinal chemistry, 2015, Apr-13, Volume: 94

    Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Least-Squares Analysis; Molecular Structure; Reproducibility of Results; Structure-Activity Relationship; Triazoles

2015
Development of Fluorescence Imaging Probes for Labeling COX-1 in Live Ovarian Cancer Cells.
    ACS medicinal chemistry letters, 2021, May-13, Volume: 12, Issue:5

    Topics:

2021
SC-560 and mofezolac isosteres as new potent COX-1 selective inhibitors with antiplatelet effect.
    Archiv der Pharmazie, 2023, Volume: 356, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship

2023